Published in J Med Chem on January 07, 1994
Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature (2001) 15.44
Genome sequence of Yersinia pestis, the causative agent of plague. Nature (2001) 14.36
The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26
Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491. Nature (2000) 9.86
The genome of the social amoeba Dictyostelium discoideum. Nature (2005) 9.18
A new type of synthetic peptide library for identifying ligand-binding activity. Nature (1991) 7.81
Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature (1997) 6.80
Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med (2001) 3.77
Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev (2007) 3.42
Muscarinic cholinergic binding in rat brain. Proc Natl Acad Sci U S A (1974) 3.35
Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. Proc Natl Acad Sci U S A (1983) 3.17
Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc Natl Acad Sci U S A (2000) 3.04
PAC-1: a mitogen-induced nuclear protein tyrosine phosphatase. Science (1993) 2.80
4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. Proc Natl Acad Sci U S A (1980) 2.80
Sequence of Plasmodium falciparum chromosomes 1, 3-9 and 13. Nature (2002) 2.59
CB2 cannabinoid receptor-mediated peripheral antinociception. Pain (2001) 2.38
Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis. J Rheumatol (1998) 2.36
Community-based cancer screening for underserved women: design and baseline findings from the Breast and Cervical Cancer Intervention Study. Prev Med (2001) 2.35
High affinity transport of choline into synaptosomes of rat brain. J Neurochem (1973) 2.35
Labile exocyclic amine protection of nucleosides in DNA, RNA and oligonucleotide analog synthesis facilitating N-deacylation, minimizing depurination and chain degradation. Biochimie (1993) 2.34
Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study. Kidney Int (2008) 2.26
Activation of two signal-transduction systems in hepatocytes by glucagon. Nature (1986) 2.21
Effect of nebulized ipratropium on the hospitalization rates of children with asthma. N Engl J Med (1998) 2.20
Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies. Biochim Biophys Acta (1999) 2.20
Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin. Pain (2001) 2.05
Behaviorism: Are reports of its death exaggerated? Behav Anal (1986) 2.04
Drugs, neurotransmitters, and schizophrenia. Science (1974) 2.00
Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin. JAMA (1991) 1.93
Distinct potassium channels on pain-sensing neurons. Proc Natl Acad Sci U S A (2001) 1.90
Characterization of symptoms in children with recurrent abdominal pain: resemblance to irritable bowel syndrome. J Pediatr Gastroenterol Nutr (1995) 1.89
Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. J Pharmacol Exp Ther (1992) 1.88
The epidemiology of acute appendicitis in California: racial, gender, and seasonal variation. Epidemiology (1991) 1.83
SR141716A is an inverse agonist at the human cannabinoid CB1 receptor. Eur J Pharmacol (1997) 1.83
Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosci (2001) 1.76
Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain. J Neurochem (1981) 1.75
Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J Neurosci (2000) 1.71
Antinuclear and antineutrophil cytoplasmic antibodies (ANCA) in the sera of patients with Felty's syndrome. Br J Rheumatol (1992) 1.69
Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J Neurosci (2001) 1.67
Integration of academic and clinical performance-based faculty compensation plans: a system and its impact on an anaesthesiology department. Br J Anaesth (2013) 1.63
A Canadian faculty of medicine and dentistry's survey of career development needs. Med Educ (2001) 1.57
Dyspepsia in children and adolescents: a prospective study. J Pediatr Gastroenterol Nutr (2000) 1.56
Choline: high-affinity uptake by rat brain synaptosomes. Science (1972) 1.55
Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics. J Med Chem (1989) 1.54
The Waikato Medical Care (WaiMedCa) Survey 1991-1992. N Z Med J (1994) 1.54
Referral and diagnosis of common rheumatic diseases by primary care physicians. Br J Rheumatol (1998) 1.54
Sarcoidosis of the small intestine. Am J Gastroenterol (1988) 1.53
Immunological studies on the mechanism of gold hypersensitivity reactions. Br Med J (1973) 1.50
The spondyloarthropathies in Zimbabwe: a clinical and immunogenetic profile. J Rheumatol (1990) 1.49
Antidepressants and the muscarinic acetylcholine receptor. Arch Gen Psychiatry (1977) 1.49
Experimental immune synovitis in the rabbit. Relative roles of cell mediated and humoral immunity. Arthritis Rheum (1975) 1.46
Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. J Pharmacol Exp Ther (1984) 1.45
A longitudinal study of in vitro tests for lymphocyte function in rheumatoid arthritis. Ann Rheum Dis (1978) 1.45
Orphanin-FQ/nociceptin: lack of anti nociceptive, hyperalgesic or allodynic effects in acute thermal or mechanical tests following intracerebroventricular or intrathecal administration to mice or rats. Eur J Pain (1998) 1.44
Lack of involvement of capsaicin-sensitive primary afferents in nerve-ligation injury induced tactile allodynia in rats. Pain (1999) 1.43
The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats. Life Sci (1982) 1.43
Statistical analysis of drug-drug and site-site interactions with isobolograms. Life Sci (1989) 1.43
Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin? Bioessays (1992) 1.42
HIV and arthritis--causal or casual acquaintances? J Rheumatol (1989) 1.42
Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ (1994) 1.42
Snake wars. Br J Gen Pract (2000) 1.40
Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. Am J Epidemiol (2001) 1.40
Descending facilitation from the rostral ventromedial medulla maintains nerve injury-induced central sensitization. Neuroscience (2006) 1.39
The interaction of [3H]nitrendipine with receptors for calcium antagonists in the cerebral cortex and heart of rats. Biochem Biophys Res Commun (1982) 1.38
Rheumatic diseases in African blacks. Semin Arthritis Rheum (1994) 1.38
Preterm infants 30-36 weeks' gestation in Victoria--where should they be delivered? Aust N Z J Obstet Gynaecol (1998) 1.38
Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats. Peptides (1991) 1.37
Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen. J Clin Invest (1994) 1.37
Hormonal regulation of Gi2 alpha-subunit phosphorylation in intact hepatocytes. Biochem J (1990) 1.37
Glial cell line-derived neurotrophic factor normalizes neurochemical changes in injured dorsal root ganglion neurons and prevents the expression of experimental neuropathic pain. Neuroscience (2003) 1.35
Pseudomonas aeruginosa induction of apoptosis in respiratory epithelial cells: analysis of the effects of cystic fibrosis transmembrane conductance regulator dysfunction and bacterial virulence factors. Am J Respir Cell Mol Biol (2000) 1.35
Sensitivity- and gradient-enhanced hetero (omega1) half-filtered TOCSY experiment for measuring long-range heteronuclear coupling constants. J Magn Reson (1998) 1.34
Molecular biology and pharmacology of cloned opioid receptors. FASEB J (1995) 1.34
Neurotransmitter receptor alterations in Parkinson's disease. Life Sci (1977) 1.34
Spinal and supraspinal mechanisms of neuropathic pain. Ann N Y Acad Sci (2000) 1.33
The delta-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy. Pharmacol Rev (1999) 1.33
Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier. Proc Natl Acad Sci U S A (1994) 1.32
Correlation between levels of DNA antibodies and clinical disease activity in SLE. Ann Rheum Dis (1977) 1.32
Conformational restrictions of biologically active peptides via amino acid side chain groups. Life Sci (1982) 1.32
Plasmon resonance studies of agonist/antagonist binding to the human delta-opioid receptor: new structural insights into receptor-ligand interactions. Biophys J (2000) 1.32
Significance of eosinophilia during gold therapy. Arthritis Rheum (1975) 1.31
Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans. J Med Chem (1999) 1.31
Association of environmental tobacco smoke exposure with socioeconomic status in a population of 7725 New Zealanders. Tob Control (1998) 1.31
SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J Pharmacol Exp Ther (1995) 1.30
Antinociceptive profile of biphalin, a dimeric enkephalin analog. J Pharmacol Exp Ther (1993) 1.30
Early postnatal discharge from hospital for healthy mothers and term infants. Cochrane Database Syst Rev (2002) 1.30
Muscimol binding in rat brain: association with synaptic GABA receptors. Brain Res (1978) 1.30
The rat paw formalin test: comparison of noxious agents. Pain (1990) 1.30